Literature DB >> 2410036

The plasma clearance of human alpha 2-macroglobulin-trypsin complex in the rat is mainly accounted for by uptake into hepatocytes.

O Davidsen, E I Christensen, J Gliemann.   

Abstract

Rats were given intravenous injections of 125I-labelled human alpha 2-macroglobulin X trypsin. The half-time of disappearance of radioactivity from arterial blood was 2 min. External counting showed that radioactivity in the liver was maximal by 10 min and then decreased slowly. 87% of the injected dose was recovered in the liver by 10 min. Light- and electron microscopic autoradiography carried out on samples of liver fixed with glutaraldehyde 3 min or 30 min after the injection showed that 85-90% of the grains were over the hepatocytes and 4-9% were over the Kupffer cells. Thus, uptake into hepatocytes, and not into Kupffer cells as believed previously, appears to account for the major part of the uptake of alpha 2-macroglobulin X trypsin by the liver and thereby for its rapid removal from the blood.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2410036     DOI: 10.1016/0167-4889(85)90113-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Recognition of chylomicron remnants and beta-migrating very-low-density lipoproteins by the remnant receptor of parenchymal liver cells is distinct from the liver alpha 2-macroglobulin-recognition site.

Authors:  M C van Dijk; G J Ziere; W Boers; C Linthorst; M K Bijsterbosch; T J van Berkel
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

2.  An alpha 2-macroglobulin receptor-dependent mechanism for the plasma clearance of transforming growth factor-beta 1 in mice.

Authors:  J LaMarre; M A Hayes; G K Wollenberg; I Hussaini; S W Hall; S L Gonias
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

3.  Immunohistochemical localization of low density lipoprotein (LDL) receptor-related protein-1 (LRP1) in the endometrium of cyclic and pregnant pigs.

Authors:  Martin Steffl; Markus Schweiger; Werner M Amselgruber
Journal:  J Mol Histol       Date:  2012-12-09       Impact factor: 2.611

4.  Role of the scavenger receptor in the uptake of methylamine-activated alpha 2-macroglobulin by rat liver.

Authors:  M C van Dijk; W Boers; C Linthorst; T J van Berkel
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

5.  Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues.

Authors:  S K Moestrup; J Gliemann; G Pallesen
Journal:  Cell Tissue Res       Date:  1992-09       Impact factor: 5.249

6.  Identification of targeting proteinase for rat alpha 1-macroglobulin in vivo. Mast-cell tryptase is a major component of the alpha 1-macroglobulin-proteinase complex endocytosed into rat liver lysosomes.

Authors:  A Tsuji; T Akamatsu; H Nagamune; Y Matsuda
Journal:  Biochem J       Date:  1994-02-15       Impact factor: 3.857

7.  Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator.

Authors:  G Bu; S Williams; D K Strickland; A L Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

8.  Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells.

Authors:  P H Jensen; E I Christensen; P Ebbesen; J Gliemann; P A Andreasen
Journal:  Cell Regul       Date:  1990-12

9.  Different zonal distribution of the asialoglycoprotein receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein and the lipoprotein-remnant receptor of rat liver parenchymal cells.

Authors:  A H Voorschuur; J Kuiper; J A Neelissen; W Boers; T J Van Berkel
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

Review 10.  HO-1 and CD39: It Takes Two to Protect the Realm.

Authors:  Ghee Rye Lee; Shahzad Shaefi; Leo E Otterbein
Journal:  Front Immunol       Date:  2019-07-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.